Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Combined Romosozumab and Raloxifene treatment targets impaired bone quality in a male murine model of diabetic kidney disease

Bone(2025)10.1016/j.bone.2025.117415Source: DataRank Database

Combined Romosozumab and Raloxifene treatment targets impaired bone quality in a male murine model of diabetic kidney disease is a research paper published in Bone (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.78)OA: greenTopics (27)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Dyann M. Segvich ORCID,Olivia N. Reul,Corinne E. Metzger ORCID,Matthew R. Allen ORCID,Joseph M. Wallace ORCID

Live enrichment

PubMed:39884489 PMC:PMC11908879 OpenAlex:https://openalex.org/W4406892950

National Institutes of Health

Grant: T32AR065971

U.S. Department of Veterans Affairs

Grant: I01 BX005990

BLRD VA

Grant: IK6 BX006479

National Institutes of Health

FWCI

3.78

Citation Percentile

0.9%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11908879/

publisherhttps://api.elsevier.com/content/article/PII:S8756328225000274?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S8756328225000274?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.bone.2025.117415

Fields of Study

Bone health and osteoporosis researchBone Metabolism and DiseasesBone health and treatments

MeSH Terms

AnimalsAntibodies, MonoclonalBone and BonesDiabetic NephropathiesDisease Models, AnimalDrug Therapy, CombinationMaleMice, Inbred C57BLBone DensityRaloxifene HydrochlorideMiceX-Ray Microtomography

Keywords

RaloxifeneMedicineDiseaseInternal medicineEndocrinologyEstrogen receptorCancerCombination treatmentDiabetesChronic Kidney DiseaseBone QualityRomosozumab

Sustainable Development Goals

SDG 0: Good health and well-being